Market revenue in 2023 | USD 763.2 million |
Market revenue in 2030 | USD 1,085.3 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.81% in 2023. Horizon Databook has segmented the Brazil neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in the number of favorable government initiatives in Brazil is expected to promote market growth. NTDs are considered public health problem in Brazil. In this country, maximum number of the world’s major NTDs are present, and the country accounts for the highest burden of these diseases in Latin America.
Brazil observed the largest number of cases of schistosomiasis, leprosy, dengue, Chagas disease, and leishmaniases in the region. In addition, according to data published in PLOS One, approximately 8,000 to 10,000 NTDrelated deaths are observed in this country each year, mostly due to Chagas disease.
Brazil is expected to hold strong opportunities for market growth. Healthcare system in the country, Unified Health System (SUS), provides free healthcare services to individuals at all levels without charging an additional amount.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Brazil neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account